跳至主要内容
临床试验/NCT04272736
NCT04272736撤回不适用

Evaluating the Compliance, Acceptability, Safety and Tolerance of a Lower Calorie Protein Substitute for the Dietary Management of Phenylketonuria in Children and Adults - a Pilot Study

Nutricia UK Ltd0 个研究点目标入组 30 人开始时间: 2023年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
入组人数
30
主要终点
Compliance

研究概览

简要总结

This study will evaluate the compliance, acceptability, gastrointestinal (GI) tolerance and safety of a lower calorie amino acid based liquid protein substitute for patients with Phenylketonuria (PKU) or hyperphenylalaninemia (HPA).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
3 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female
  • 3 years of age or above
  • Diagnosed with classical or variant type phenylketonuria (PKU), or hyperphenylalaninemia (HPA)
  • Have been compliant in taking at least one amino acid-based, Phe-free protein substitute, providing at least 20g protein equivalent daily, for at least 1 month prior to study commencement
  • Have a prescribed daily Phe allowance
  • Written informed consent from patient, or from parent / carer if applicable

排除标准

  • Pregnant or lactating
  • Requiring enteral tube or parenteral nutrition
  • Major hepatic or renal dysfunction
  • Participation in other studies within 1 month prior to entry to this study
  • Allergy to any of the study product ingredients
  • Investigator concern around the patient being underweight (e.g.: BMI lower than 18.5kg/m2 for adults) and/or having an eating disorder
  • Investigator concern around willingness/ability of patient or parent/carer to comply with protocol requirements

结局指标

主要结局

Compliance

时间窗: Daily for 31 days

Questionnaire on amounts offered and amounts actually consumed, compared to recommended amount. Amounts (values) are recorded

次要结局

  • Blood phenylalanine and other amino acid levels(Recorded at baselien and end of intervention (day 31))
  • Gastro-intestinal tolerance(recorded at baseline, beginning of intervention and end of intervention(12 out of 31 days in total))
  • Anthropometry(Recorded at baseline and end of intervention (day 31))
  • Acceptability: Tick-box questionnaire(Recorded at baseline and end of intervetnion (day 31))
  • Nutrient intake(Recorded at basleine and end of intervention (day 31))

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

PKU Low Calorie Drink Study | 临床试验